ARAY

Accuray Incorporated Healthcare - Medical Devices Investor Relations →

YES
82.7% BELOW
↑ Moving away Was -83.2% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $2.01
14-Week RSI 48
Rel. Volume (14w) This week's trading vs. the 14-week average 0.4x — Quiet
Buyers vs. Sellers (14w) Are up-weeks or down-weeks getting more volume? 0.81

Accuray Incorporated (ARAY) closed at $0.35 as of 2026-06-19, trading 82.7% below its 200-week moving average of $2.01. This places ARAY in the extreme value zone. The stock moved further from the line this week, up from -83.2% last week. The 14-week RSI sits at 48, indicating neutral momentum.

Trading volume is running at 0.4x of its 14-week average, which is in the normal range. The balance between buying and selling volume (0.81 ratio) is neutral — neither side is clearly dominating.

Over the past 962 weeks of data, ARAY has crossed below its 200-week moving average 20 times. On average, these episodes lasted 38 weeks. The average one-year return after crossing below was -13.8%, suggesting these dips have not historically been reliable buying opportunities for this stock.

With a market cap of $41 million, ARAY is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -101.1%. The stock trades at 1.0x book value.

Share count has increased 20.5% over three years, indicating dilution.

Over the past 18.5 years, a hypothetical investment of $100 in ARAY would have grown to $3, compared to $763 for the S&P 500. ARAY has returned -16.7% annualized vs 11.6% for the index, underperforming the broader market over this period.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Business Health

Annual financials — how the underlying business has performed over the past several years.

Cash Flow Free cash flow & net income ($M)

Revenue Annual revenue ($M) — business growth proxy

Total Debt Balance sheet debt ($M)

ROIC Return on invested capital (%)

FCF Yield Free cash flow / market cap (%) — Yartseva signal

Gross Margin Pricing power & competitive moat (%)

Shares Outstanding Buybacks vs dilution (millions)

Growth of $100: ARAY vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After ARAY Crosses Below the Line?

Across 20 historical episodes, buying ARAY when it crossed below its 200-week moving average produced an average return of -13.7% after 12 months (median -13.0%), compared to +7.4% for the S&P 500 over the same periods. 30% of those episodes were profitable after one year. After 24 months, the average return was -7.3% vs +29.4% for the index.

Each line shows $100 invested at the moment ARAY crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Bean Score Experimental

The Bean Score measures how far a stock's free cash flow yield has deviated from its own quarterly baseline, normalized by the stock's historical behavior. ARAY currently has negative free cash flow, so price-based dislocation levels are not available. The score still tracks yield deviation from baseline.

Current Bean Score -0.84σ
Current FCF Yield -82.22%
Baseline Yield -66.94%
Historical σ 9.64pp

Quarterly FCF & Yield Trailing twelve-month free cash flow and yield at each quarter end

Data depth: 2 quarterly baselines, 22 price observations — Limited history (4+ quarters preferred for reliability)

Signal Accuracy Collecting Data

The Bean Score system is accumulating weekly data to validate signal accuracy. After 13+ weeks of history, this section will display win rates and average returns for each σ threshold crossing — answering the question: "When this score says cheap or expensive, does the price subsequently move in the expected direction?"

11 / 13 weeks minimum

Theoretical framework — not backtested or forward-tested. The Bean Score uses trailing twelve-month free cash flow yield as a dislocation identifier. It measures whether the market has pushed a stock's yield unusually far from its own baseline behavior. These levels are reference points for identifying potential swing trade opportunities, not buy/sell signals. FCF values update quarterly with earnings; between reports, all movement is price-driven.

Dislocation Scores Experimental

Each score measures deviation from ARAY's own historical baseline — the same idea as the Bean Score, applied to different fundamentals. Positive means cheaper or more dislocated than this stock's norm. Scores marked σ are normalized by the stock's own variability; pp values are simple deltas from its recent baseline.

2 stacked signals: drawdown, insider
Yield Dislocation N/A Dividend yield vs own 10-yr norm
Drawdown Score +2.28σ Distance from line vs own history
Sector-Relative +1.31σ Vs sector median this week
Buyback Acceleration +6.0pp YoY share change vs own 3-yr pace (− = accelerating)
Insider Intensity 92th TTM buys / market cap, percentile of buyers
FCF Yield vs History -22.7pp Vs own recent annual mean
Earnings Quality Stable Accrual gap trend (+2.3pp of revenue)

Theoretical framework — not backtested. These scores describe how unusual today's readings are for this specific company. They are starting points for research, not buy or sell signals. Annual-statement scores (buyback, accruals, FCF vs history) rest on only ~4 yearly data points and are deltas, not sigmas.

Advertisement

Historical Touches

ARAY has crossed below its 200-week MA 20 times with an average 1-year return of +-13.8% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Jan 2008Jan 201115971.2%-67.2%-97.9%
May 2011Jun 2011810.6%-11.4%-95.6%
Jul 2011Feb 20122848.9%-6.4%-95.0%
Feb 2012Mar 201210.3%-35.3%-94.6%
May 2012Jun 201257.3%-11.6%-94.2%
Jul 2012Jul 201210.1%-10.6%-94.5%
Jul 2012Aug 201210.6%+0.6%-94.5%
Aug 2012Sep 201247.8%+4.0%-94.2%
Nov 2012Dec 201243.1%+32.4%-94.5%
Dec 2012Aug 20133434.7%+37.4%-94.5%
Oct 2014Nov 201427.9%+5.8%-94.5%
Dec 2014Dec 201411.2%+0.6%-94.9%
May 2015Jun 201559.0%-21.6%-94.6%
Jun 2015Nov 20151823.9%-24.6%-94.9%
Nov 2015Feb 201917040.8%-22.1%-94.9%
Mar 2019Nov 20208964.1%-41.5%-92.7%
Aug 2021Aug 202125.5%-26.6%-90.5%
Sep 2021Sep 202124.9%-35.0%-90.5%
Jan 2022Apr 20236551.0%-28.5%-90.0%
Aug 2023Ongoing150+86.9%Ongoing-88.7%
Average38+-13.8%

Frequently Asked Questions

Is ARAY below its 200-week moving average?

Yes. As of 2026-06-19, Accuray Incorporated (ARAY) is trading 82.7% below its 200-week moving average of $2.01. The current price is $0.35.

What is ARAY's 200-week moving average price?

Accuray Incorporated's 200-week moving average is $2.01 as of 2026-06-19. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.

What happens when ARAY drops below its 200-week moving average?

ARAY has crossed below its 200-week moving average 20 times in our data. The average one-year return after these crossings was -13.8%, meaning the dips were not reliable buying signals for this particular stock. These episodes lasted 38 weeks on average.

Is ARAY a good value right now?

Here's what our data says about ARAY as of 2026-06-19: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 48. Free cash flow is currently negative. Return on equity is -101.1%. Price-to-book is 1.0x. This is not a buy or sell recommendation — always do your own research.

How does ARAY compare to the S&P 500?

Over the past 18.5 years, $100 invested in ARAY would have grown to $3, compared to $763 for the S&P 500. That's -16.7% annualized vs 11.6% for the index. ARAY has underperformed the broader market over this period.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of week of 2026-06-19